Natera, Inc. (NASDAQ:NTRA) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET

Company Participants

Steven Chapman - Chief Executive Officer

Michael Brophy - Chief Financial Officer

Alexey Aleshin - Chief Medical Officer

John Fesko - Chief Business Officer

Conference Call Participants

Tejas Savant - Morgan Stanley

Puneet Souda - SVB Securities

Thomas Peterson - Baird

Daniel Brennan - TD Cowen

Alexander Nowak - Craig-Hallum

Operator

Hello. Welcome to Natera's 2023 First Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, May 9, 2023. I would now like to turn the call -- conference call over to Mike Brophy, Chief Financial Officer. Please go ahead.

Michael Brophy

Thanks, operator. Good afternoon. Thank you for joining our conference call to discuss the results of our first quarter of 2023. On the line, I am joined by Steve Chapman, our CEO; Alex Aleshin, Chief Medical Officer, stepping in for Solomon Moshkevich, who wasn't able to join the call today due to company business; and John Fesko, Chief Business Officer. Today's conference call is being broadcast live via webcast. We will be referring to a slide presentation that has been posted to investor.natera.com. A replay of the call will also be close to our IR site as soon as it's available.

Starting on Slide two. During the course of this conference call, we will make forward-looking statements regarding future events and our anticipated future performance such as our operational and financial outlook and projections, our assumptions for that outlook, market size, partnerships, clinical studies, opportunities and strategies and expectations for various hiring future products, including product capabilities, we expect to release dates, reimbursement coverage and related effects on our financial and operating results.

We caution you that such statements reflect our better it based on the factors currently not a and actual events or results could differ materially. Please refer to the documents we file from time to time with the SEC, including our most recent Form 10-K or 10-Q and the Form 8-K filed with today's press release. Those documents identify important risks and other factors that may cause our actual results to differ materially from those contained in or suggested by forward-looking statements.

Forward-looking statements made during the call are being made as of today, May 9, 2023. If this call is replayed or reviewed after today, the information presented during the call may not contain current or accurate information. Natera disclaims any obligation to update or revise any forward-looking statements. We will provide guidance on today's call, but will not provide any further guidance or updates on form during the quarter, unless we do so in a public forum. We will quote a number of numerical growth changes as we discuss our financial performance. And unless otherwise noted, each such reference represents a year-on-year comparison.